These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 13400879)

  • 1. Changes in plasma prothrombin, Ac-globulin, and antithrombin concentration following intravenous administration of estrogens.
    JOHNSON JF
    Proc Soc Exp Biol Med; 1957 Jan; 94(1):92-4. PubMed ID: 13400879
    [No Abstract]   [Full Text] [Related]  

  • 2. INACTIVATION OF PURIFIED AUTOPROTHROMBIN I WITH ANTITHROMBIN.
    SEEGERS WH; SCHROEER H; KAGAMI M
    Can J Biochem; 1964 Oct; 42():1425-35. PubMed ID: 14240727
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacologic modulation of thrombin generation associated with human clots by human purified antithrombin alone or in the presence of low molecular weight heparin or unfractionated heparin.
    Meddahi S; Bara L; Fessi H; Samama MM
    Blood Coagul Fibrinolysis; 2000 Jan; 11(1):51-9. PubMed ID: 10691099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antithrombin III: a backward glance o'er travel'd roads.
    Seegers WH
    Adv Exp Med Biol; 1975; 52():195-215. PubMed ID: 47704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of oral and intravenous administration of vitamins K on the prothrombin and proconvertin levels of cholecystnephrostomized dogs.
    FISHER LM; JAQUES LB; MILLAR GJ
    Can J Biochem Physiol; 1956 Sep; 34(5):1039-51. PubMed ID: 13364731
    [No Abstract]   [Full Text] [Related]  

  • 6. Thrombin generation and formation of thrombin-antithrombin III complexes in congenital antithrombin III deficiency.
    Boyer C; Wolf M; Lavergne JM; Larrieu MJ
    Thromb Res; 1980 Oct; 20(2):207-18. PubMed ID: 7209877
    [No Abstract]   [Full Text] [Related]  

  • 7. The existence of variations in the ease with which thrombin preparations may be inactivated by antithrombin.
    CARTER JR; SMITH HP
    Fed Proc; 1946; 5(1 Pt 2):219. PubMed ID: 20984560
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies on an antithrombin. III. A plasma antithrombin test for the prediction of intravascular clotting.
    KAY JH; HUTTON SB; WEISS GN; OCHSNER A
    Surgery; 1950 Jul; 28(1):24-8. PubMed ID: 15442785
    [No Abstract]   [Full Text] [Related]  

  • 9. An antithrombin reaction to prothrombin activation.
    Seegers WH; Johnson JF; Fell C
    Am J Physiol; 1954 Jan; 176(1):97-103. PubMed ID: 13124503
    [No Abstract]   [Full Text] [Related]  

  • 10. Quantitative aspects of antithrombin and heparin in plasma.
    WAUGH DF; FITZGERALD MA
    Am J Physiol; 1956 Mar; 184(3):627-39. PubMed ID: 13302473
    [No Abstract]   [Full Text] [Related]  

  • 11. [The significance of prothrombin, antithrombin and fibrinogen for the shortening of the blood coagulation rate during surgery and anesthesia].
    WILLE P
    Zentralbl Gynakol; 1959 Jul; 81():1195-200. PubMed ID: 13844795
    [No Abstract]   [Full Text] [Related]  

  • 12. THE KINETICS OF THROMBIN ACTIVITY IN RECALCIFIED BLOOD PLASMA.
    GRANNIS GF; KAZAL LA; TOCANTINS LM
    Thromb Diath Haemorrh; 1965 Jun; 13():361-72. PubMed ID: 14347860
    [No Abstract]   [Full Text] [Related]  

  • 13. [Plasma content of accelerator and antithrombin active substance in dicumarol induced prothrombinemia].
    HOENE R; MULLER M; SCHULZ W
    Hoppe Seylers Z Physiol Chem; 1953 Jan; 291(5-6):199-212. PubMed ID: 13060907
    [No Abstract]   [Full Text] [Related]  

  • 14. Inhibition of factor X and factor V activation by dermatan sulfate and a pentasaccharide with high affinity for antithrombin III in human plasma.
    Ofosu FA; Choay J; Anvari N; Smith LM; Blajchman MA
    Eur J Biochem; 1990 Oct; 193(2):485-93. PubMed ID: 2226466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of plasma antithrombin concentration on thrombin generation and fibrin gel structure.
    Elgue G; Sanchez J; Fatah K; Olsson P; Blombäck B
    Thromb Res; 1994 Jul; 75(2):203-12. PubMed ID: 7974394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NEUTRALIZATION OF AUTOPROTHROMBIN C ACTIVITY WITH ANTITHROMBIN.
    SEEGERS WH; COLE ER; HARMISON CR; MONKHOUSE FC
    Can J Biochem; 1964 Mar; 42():359-64. PubMed ID: 14164282
    [No Abstract]   [Full Text] [Related]  

  • 17. Deciphering the coagulation profile through the dynamics of thrombin activity.
    de Laat-Kremers RMW; Yan Q; Ninivaggi M; de Maat M; de Laat B
    Sci Rep; 2020 Jul; 10(1):12544. PubMed ID: 32719370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Plasma antithrombin and thrombin inhibitor in liver parenchymal and bile duct disease].
    WITTE S; DIRNBERGER P
    Klin Wochenschr; 1955 Aug; 33(29-30):705-9. PubMed ID: 13264505
    [No Abstract]   [Full Text] [Related]  

  • 19. Coagulant proteins and thrombin generation in synovial fluid: a model for extravascular coagulation.
    Chang P; Aronson DL; Borenstein DG; Kessler CM
    Am J Hematol; 1995 Oct; 50(2):79-83. PubMed ID: 7573004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Thrombin time and antithrombin power of human plasma in the presence of heparin and some synthetic heparinoids].
    BURSTEIN M; GUINAND A
    J Physiol (Paris); 1955; 47(1):115-7. PubMed ID: 13243272
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.